The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 18, 2014

Filed:

Oct. 11, 2012
Applicant:

Teva Pharmaceutical Industries, Ltd., Petach-Tikva, IL;

Inventors:

Hussein Hallak, East Jerusalem, IL;

Nora Tarcic, Modiin, IL;

Joel Flaxman Kaye, Netanya, IL;

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C07K 14/47 (2006.01); A01N 43/42 (2006.01); A61K 31/47 (2006.01); A01N 33/02 (2006.01); A61K 31/135 (2006.01); A61K 31/4704 (2006.01); A61K 31/137 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4704 (2013.01); A61K 31/137 (2013.01);
Abstract

This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject laquinimod as an add-on therapy to or in combination with fingolimod. This invention also provides a package and a pharmaceutical composition comprising laquinimod and fingolimod for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides laquinimod for use as an add-on therapy or in combination with fingolimod in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and fingolimod in the preparation of a combination for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome.


Find Patent Forward Citations

Loading…